-
Rad Chat live #4 with Igor Bessières and Mathieu Gonod at the Surface Guided Radiation Therapy Annual European Meeting 2024.
- 2024/12/11
- 再生時間： 12 分
- ポッドキャスト
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Rad Chat live #4 with Igor Bessières and Mathieu Gonod at the Surface Guided Radiation Therapy Annual European Meeting 2024.
-
サマリー
あらすじ・解説
Naman Julka-Anderson and Jo McNamara catch up Igor Bessières and Mathieu Gonod. MapRT helps to make treatments fast, easy and safe. It uses SGRT to deliver a “clearance map”, which planners use to check which beams are deliverable during plan creation. In this podcast episode, Medical Physicists Igor Bessières and Mathieu Gonod from Centre Georges-François Leclerc share their firsthand experience with this innovative technology and its impact on treatment planning. To use this podcast as CPD, look at these reflection points: 1) reflect on Igor and Mathieu’s experience of gathering data to showcase the benefits of new technology.2) consider the barriers and enablers to dynamic trajectory radiotherapy.3) find out more about the SGRT community, resources and videos about their technology: https://sgrt.org/Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.Curious about clearance mapping? Dive into the comprehensive video library here or explore surface guidance for better radiation therapy planning here. Learn more about SGRT and connect with the community by visiting the SGRT Community website.References from Igor and Mathieu’s presentations: Benchmarking MapRT and first clinical experience: a novel solution for collision-free non-co-planar treatment planning - Journal of Applied Clinical Medical Physics (In Press) DOI: 10.1002/acm2.14572.Tolerance of normal tissue to therapeutic irradiation (1991). International Journal of Radiation Oncology, Biology and Physics. DOI: 10.1016/0360-3016(91)90171-Tolerance of normal tissue to therapeutic radiation (2013). Reports of radiotherapy and Oncology: https://applications.emro.who.int/imemrf/Rep_Radiother_Oncol/Rep_Radiother_Oncol_2013_1_1_35_48.pdfTreatment Site Specific:Lung:Kim et al. (2020) DOI: 10.1259/bjr.20190596Ma et al. (2021) DOI: 10.1002/acm2.13197Head & Neck:Gayen et al. (2020) DOI: 10.3857/roj.2020.00143Woods et al. (2022) DOI: 10.3390/cancers14040939Mediastinal:Rossi et al. (2021) DOI: 10.3389/fonc.2021.619929Breast: Frengen et al. (2023) DOI: 10.1080/0284186X.2023.2264488SBRT:Biau et al. (2022) DOI: 10.1016/j.ctro.2022.11.007Lincoln et al. (2023) DOI: 10.1088/1361-6560/ace23fMulti:Bertholet et al. (2023) DOI: 10.1002/mp.16899Loebner et al. (2023) DOI: 10.1002/mp.16533Dynamic Trajectory RadioTherapy(DTRT): Dosimetric optimization for dynamic mixed beam arc therapy (DYMBARC) (2024): https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/mp.17467 Impact of the gradient in gantry-table rotation on dynamic trajectory radiotherapy plan quality (2023): https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/mp.16749 A dosimetrically motivated pathfinding approach for non-isocentric dynamic trajectory radiotherapy (2024): https://iopscience.iop.org/article/10.1088/1361-6560/ad75e1Watch this episode on YouTube: https://www.youtube.com/watch?v=9nHM1AH81S0Please like and subscribe to Rad Chat on your podcast library.Our links:Link Tree:https://linktr.ee/radchat Facebook:https://www.facebook.com/RadChatPodcast/ Instagram:https://www.instagram.com/rad__chat/ LinkedIn:https://uk.linkedin.com/company/radtalk Tik Tok:https://www.tiktok.com/@rad_chat Twitter:https://twitter.com/rad__chat?lang=en YouTube: https://www.youtube.com/@radchat2259Music and jingle credits: Dr. Ben Potts and Adam Cooke.